Scientific Diligence Memo
We review a discovery-stage data package from the standpoint of a scientist who has run these assays. The memo states what the data support, where the replication risk lies, and which questions to put to management, with the answer to each that would change the conclusion.
Decision it supports. Whether a data package supports an investment or a partnering decision.
- For
-
A venture investor, or a pharma business development and search-and-evaluation team, with a discovery-stage asset and a data package.
- Scope
-
One asset or one data package, from in vitro through translational work. We can assess proteinopathy and seeding models, glial and inflammasome readouts, MEA and calcium data, antibody functional data, siRNA and ASO knockdown and delivery, receptor occupancy and ex vivo PK/PD packages, biofluid biomarkers, and the quantification of immunofluorescence tissue sections.
- Inputs
-
Access to the data room under the client's NDA. The client first confirms that its NDA with the target permits disclosure to advisors.
- Deliverable
-
The memo comes at two depths. The red-flag memo contains the red-flag table and the management questions. The full Diligence Memo, 8 to 15 pages, adds:
- a credibility score for the assay behind each key claim
- an assessment of replication and artifact risk
- an assessment of whether the mechanism of action is coherent
- a statement of what the data do and do not support
- Timeline
-
Three to five business days for the red-flag memo and five to ten for the full memo. A five-business-day rush on the full memo is available at a premium.
- Excluded
-
The memo is not investment advice. It is for the client's internal use and carries no third-party reliance. We decline any target on which Thalamus has a conflict, as set out in the conflicts policy. (/terms/#conflicts)
- Referred out
-
The memo does not assess how a staining assay or an animal study was designed. Where a thesis depends on either, the memo says so and a co-reviewer is needed.
Neurodegeneration and proteinopathyNeuroimmunology and gliaImmunology and translationalNeuronal function
Book a 30-minute call You answer a few short questions and choose a time. On the call we discuss your work and the decision you need to make.